Philippe Autier

Summary

Country: France

Publications

  1. ncbi Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials
    Philippe Autier
    International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372 Lyon, France
    Arch Intern Med 167:1730-7. 2007
  2. ncbi 'Environment' in cancer causation and etiological fraction: limitations and ambiguities
    Paolo Boffetta
    International Agency for Research on Cancer, 150 cours Albert-Thomas, 69008 Lyon, France
    Carcinogenesis 28:913-5. 2007
  3. ncbi Plasma phospholipid fatty acid profiles and their association with food intakes: results from a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition
    Mitra Saadatian-Elahi
    International Agency for Research on Cancer, Lyon, France
    Am J Clin Nutr 89:331-46. 2009
  4. ncbi Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations
    Mazda Jenab
    Lifestyle and Cancer Group, IARC, 150 cours Albert Thomas, 69008, Lyon, France
    Cancer Epidemiol Biomarkers Prev 18:2485-91. 2009
  5. ncbi Is FOB screening really the answer for lowering mortality in colorectal cancer?
    Philippe Autier
    Centre for Research in Epidemiology CRESIS, Luxembourg Health Institute, Luxembourg, Luxembourg
    Recent Results Cancer Res 163:254-63; discussion 264-6. 2003
  6. ncbi The impact of reimbursement criteria on the appropriateness of 'statin' prescribing
    Philippe Autier
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Eur J Cardiovasc Prev Rehabil 10:456-62. 2003
  7. ncbi Re: Sun exposure and mortality from melanoma
    Philippe Autier
    J Natl Cancer Inst 97:1159; author reply 1159-60. 2005
  8. ncbi Cancer survival statistics should be viewed with caution
    Philippe Autier
    Lancet Oncol 8:1050-2; author reply 1053-4. 2007

Collaborators

Detail Information

Publications8

  1. ncbi Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials
    Philippe Autier
    International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372 Lyon, France
    Arch Intern Med 167:1730-7. 2007
    ..We examined the risk of dying from any cause in subjects who participated in randomized trials testing the impact of vitamin D supplementation (ergocalciferol [vitamin D(2)] or cholecalciferol [vitamin D(3)]) on any health condition...
  2. ncbi 'Environment' in cancer causation and etiological fraction: limitations and ambiguities
    Paolo Boffetta
    International Agency for Research on Cancer, 150 cours Albert-Thomas, 69008 Lyon, France
    Carcinogenesis 28:913-5. 2007
  3. ncbi Plasma phospholipid fatty acid profiles and their association with food intakes: results from a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition
    Mitra Saadatian-Elahi
    International Agency for Research on Cancer, Lyon, France
    Am J Clin Nutr 89:331-46. 2009
    ..Plasma phospholipid fatty acids have been correlated with food intakes in populations with homogeneous dietary patterns. However, few data are available on populations with heterogeneous dietary patterns...
  4. ncbi Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations
    Mazda Jenab
    Lifestyle and Cancer Group, IARC, 150 cours Albert Thomas, 69008, Lyon, France
    Cancer Epidemiol Biomarkers Prev 18:2485-91. 2009
    ..These results confirm a role for the BsmI polymorphism of the VDR gene in CRC risk, independent of serum 25OHD concentration and dietary calcium intake...
  5. ncbi Is FOB screening really the answer for lowering mortality in colorectal cancer?
    Philippe Autier
    Centre for Research in Epidemiology CRESIS, Luxembourg Health Institute, Luxembourg, Luxembourg
    Recent Results Cancer Res 163:254-63; discussion 264-6. 2003
    ..Therefore, recommending general population screening with biennial FOBT is still an open question...
  6. ncbi The impact of reimbursement criteria on the appropriateness of 'statin' prescribing
    Philippe Autier
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Eur J Cardiovasc Prev Rehabil 10:456-62. 2003
    ..Regulation based on blood cholesterol level encourages the overlooking of other risk factors relevant for selecting patients having the greatest chance to benefit from statin treatment...
  7. ncbi Re: Sun exposure and mortality from melanoma
    Philippe Autier
    J Natl Cancer Inst 97:1159; author reply 1159-60. 2005
  8. ncbi Cancer survival statistics should be viewed with caution
    Philippe Autier
    Lancet Oncol 8:1050-2; author reply 1053-4. 2007